Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial
Authors
Keywords
-
Journal
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume -, Issue -, Pages ASN.2018101058
Publisher
American Society of Nephrology (ASN)
Online
2019-05-14
DOI
10.1681/asn.2018101058
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability
- (2018) Andrew J. King et al. Science Translational Medicine
- Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia
- (2017) Steven Fishbane et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study
- (2017) Aurélie Lenglet et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Nicotinamide and phosphate homeostasis in chronic kidney disease
- (2016) Charles Ginsberg et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
- (2016) Valentin David et al. KIDNEY INTERNATIONAL
- Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD
- (2015) T. Isakova et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Efficacy and safety of nicotinamide in the management of hyperphosphatemia in pediatric patients on regular hemodialysis
- (2015) Radwa El Borolossy et al. PEDIATRIC NEPHROLOGY
- Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover study
- (2014) Joachim H Ix et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Cardiovascular Effects of Sevelamer in Stage 3 CKD
- (2013) C. D. Chue et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Relationships Between Serum and Urine Phosphorus With All-Cause and Cardiovascular Mortality: The Osteoporotic Fractures in Men (MrOS) Study
- (2012) Julie R. Dominguez et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals
- (2012) Joachim H. Ix et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Phosphate Binders in Moderate CKD
- (2012) G. A. Block et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Npt2b Deletion Attenuates Hyperphosphatemia Associated with CKD
- (2012) S. C. Schiavi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Oral calcium carbonate affects calcium but not phosphorus balance in stage 3–4 chronic kidney disease
- (2012) Kathleen M. Hill et al. KIDNEY INTERNATIONAL
- Relation of Sex and Estrogen Therapy to Serum Fibroblast Growth Factor 23, Serum Phosphorus, and Urine Phosphorus: The Heart and Soul Study
- (2011) Joachim H. Ix et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients
- (2011) E. Gonzalez-Parra et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice
- (2011) E. G. Farrow et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease
- (2010) T. Isakova et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?
- (2009) R. B. Oliveira et al. Clinical Journal of the American Society of Nephrology
- A Randomized, Double-Blind, Placebo-Controlled Trial of Niacinamide for Reduction of Phosphorus in Hemodialysis Patients
- (2008) S. C. Cheng et al. Clinical Journal of the American Society of Nephrology
- Serum Phosphorus Levels Associate with Coronary Atherosclerosis in Young Adults
- (2008) R. N. Foley et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started